Earnings per share for the last twelve months: Bioceres Crop Solutions Corp. (BIOX)

Public company logo of Bioceres Crop Solutions Corp. (BIOX)

The commercialization of HB4 drought-tolerant crops has driven financial growth for Bioceres Crop Solutions (BIOX), as evidenced by the rolling revenue per share metric, which remains at -0.76. This success is based on the expansion of biostimulants in the Americas. Meanwhile, the global food shortage is stimulating demand, despite cost inflation and trade restrictions affecting seed exports.

BIOX (Bioceres Crop Solutions) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/12/2026

Analytical breakdowns for Bioceres Crop Solutions Corp. (BIOX)

- company stock exchange capitalization indicators:
Summary company analytics:Bioceres Crop Solutions (BIOX)
Flagship merchandise of Bioceres Crops

The scalability of Bioceres Crop Solutions (BIOX) biotechnology allows the company to convert one-time breeding costs into global royalties, sharply increasing the return per share. By analyzing the 12-month rolling EPS, an investor can see net income distributed across the entire share issuance, which objectively confirms the efficiency of capital management and the fundamental stability of the company's business model.